Home » Newsletters » BioWorld

BioWorld

Nov. 16, 1993

View Archived Issues

BISPECIFIC MAB DESIGNATED ORPHAN DRUG FOR CANCER

HIGH RESPONSE RATE TO TAXOTERE IN BREAST CANCER

AFFYMAX CREATES NEW LARGE-SCALE DRUG SCREEN

GENE THERAPY COMMITTEE FORMED IN BRITAIN

INCYTE TALLIES $17.25 MILLION FROM IPO

MACROCHEM'S PRIVATE PLACEMENT DECLARED EFFECTIVE

MEDIMMUNE'S CMV TREATMENT EFFECTIVE

BRITISH HOPE TO EXPLOIT GENETIC INFORMATION

JOINT VENTURE TO DEVELOP GLUCANS AS ADJUVANTS

BIOTECH SHUT OUT OF SENATE HEARING